title: Natural history of patients developing thrombocytopenia while receiving anticoagulant therapy for venous thromboembolism.
authors.forename: P
authors.initials: P
authors.lastname: Di Micco
authors.forename: A
authors.initials: A
authors.lastname: Fontanella
authors.forename: N
authors.initials: N
authors.lastname: Falvo
authors.forename: C
authors.initials: C
authors.lastname: Bonithon-Kopp
authors.forename: H
authors.initials: H
authors.lastname: Decousus
authors.forename: A
authors.initials: A
authors.lastname: Riera-Mestre
authors.forename: M
authors.initials: M
authors.lastname: Monreal
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects*; D018450:Disease Progression; D005060:Europe; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D012042:Registries; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D055502:Secondary Prevention; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D013997:Time Factors; D054556:Venous Thromboembolism / Q000150:complications / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants